Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoblastic Lymphadenopathy × Methylprednisolone × 90 days × Clear all

Sponsor

Conditions

Burkitt Lymphoma 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Leukemia, Biphenotypic, Acute 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Multiple Myeloma 2 Lymphoma, Follicular 2 Hematologic Neoplasms 2 Drug-Related Side Effects and Adverse Reactions 2 Skin Neoplasms 1 Recurrence 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Down Syndrome 1 Cranial Nerve Diseases 1 Colitis 1 Brain Neoplasms 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

Cyclophosphamide 2 tazemetostat 1 romidepsin 1 pembrolizumab 1 glofitamab 1 fludarabine 1 etoposide phosphate 1 duvelisib 1 brincidofovir 1 belinostat 1 Vincristine 1 Valganciclovir 1 Therapeutics 1 Prednisone 1 Prednisolone 1 Polymerase Chain Reaction 1 Melphalan 1 Lactones 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Etoposide 1 Doxorubicin 1 Depsipeptides 1 Cytarabine 1 Cholecalciferol 1 Carmustine 1 Bendamustine Hydrochloride 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡